The researchers measured for a ‘primary composite outcome’, including stillbirth, death in the first few days of life, low oxygen levels, and breathing problems). While overall there was no difference between the groups in the numbers of babies with these problems, six babies in the ‘expectant management’ group died compared with none in the group induced at 41 weeks, so the trial was stopped early. These were five stillbirths and one early neonatal death. Fewer babies in the group induced at 41 weeks were admitted to a neonatal intensive care unit.